SPAST and antiphospholipid syndrome: Subject II.3 presented type 4 spastic paraplegia with an intragenic heterozygous deletion of the SPAST gene (2p22.3), anti-phospholipid syndrome with suspected neurological involvement, bilateral retinal detachment, endometriosis, recurrent oral ulceration, alopecia, and splenomegaly.